Holen Sie sich die Stockscreener-App
536.15
1.07%
5.69
Handel nachbörslich:
540.00
3.85
+0.72%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ISRG?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$530.46
Offen:
$532.74
24-Stunden-Volumen:
1.31M
Relative Volume:
0.62
Marktkapitalisierung:
$184.87B
Einnahmen:
$8.71B
Nettoeinkommen (Verlust:
$2.48B
KGV:
78.61
EPS:
6.82
Netto-Cashflow:
$1.75B
1W Leistung:
+3.95%
1M Leistung:
+15.64%
6M Leistung:
+2.26%
1J Leistung:
+37.95%
1-Tages-Spanne:
$528.87
$539.05
1-Wochen-Bereich:
$512.67
$539.05
52-Wochen-Spanne:
$379.67
$616.00
Intuitive Surgical Inc Stock (ISRG) Company Profile
Firmenname
Intuitive Surgical Inc
Sektor
Telefon
(408) 523-2100
Adresse
1020 KIFER ROAD, SUNNYVALE
Vergleichen Sie ISRG mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ISRG
Intuitive Surgical Inc
|
536.15 | 184.87B | 8.71B | 2.48B | 1.75B | 6.82 |
|
ALC
Alcon Inc
|
96.10 | 48.28B | 9.91B | 1.02B | 665.00M | 2.05 |
|
BDX
Becton Dickinson Co
|
167.14 | 47.99B | 20.87B | 1.50B | 2.59B | 5.24 |
|
RMD
Resmed Inc
|
244.70 | 35.94B | 5.02B | 1.31B | 1.56B | 8.91 |
|
COO
The Cooper Companies, Inc.
|
81.25 | 16.18B | 3.90B | 392.30M | 288.10M | 1.95 |
Intuitive Surgical Inc Stock (ISRG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-02 | Hochstufung | Redburn Atlantic | Neutral → Buy |
| 2024-07-10 | Bestätigt | Citigroup | Buy |
| 2024-05-30 | Eingeleitet | Goldman | Buy |
| 2023-11-17 | Eingeleitet | HSBC Securities | Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-04-19 | Bestätigt | BTIG Research | Buy |
| 2023-04-19 | Bestätigt | BofA Securities | Buy |
| 2023-04-19 | Bestätigt | Citigroup | Buy |
| 2023-04-19 | Bestätigt | Evercore ISI | In-line |
| 2023-04-19 | Bestätigt | JP Morgan | Overweight |
| 2023-04-19 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2023-04-19 | Bestätigt | RBC Capital Mkts | Outperform |
| 2023-04-19 | Bestätigt | Raymond James | Outperform |
| 2023-04-19 | Bestätigt | Stifel | Buy |
| 2023-04-19 | Bestätigt | Truist | Buy |
| 2023-04-19 | Bestätigt | Wells Fargo | Overweight |
| 2023-03-29 | Eingeleitet | UBS | Neutral |
| 2023-03-23 | Eingeleitet | William Blair | Outperform |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-13 | Eingeleitet | Mizuho | Neutral |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-04-13 | Eingeleitet | Truist | Buy |
| 2022-04-06 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-03-25 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-02-02 | Hochstufung | UBS | Neutral → Buy |
| 2022-01-31 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-01-25 | Herabstufung | Redburn | Buy → Neutral |
| 2022-01-21 | Bestätigt | BTIG Research | Buy |
| 2022-01-21 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-01-21 | Bestätigt | Deutsche Bank | Hold |
| 2022-01-21 | Bestätigt | Evercore ISI | In-line |
| 2022-01-21 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-01-21 | Bestätigt | Piper Sandler | Neutral |
| 2022-01-21 | Bestätigt | Raymond James | Outperform |
| 2022-01-21 | Bestätigt | Robert W. Baird | Outperform |
| 2022-01-21 | Bestätigt | Stifel | Buy |
| 2022-01-21 | Bestätigt | UBS | Neutral |
| 2022-01-21 | Bestätigt | Wells Fargo | Overweight |
| 2022-01-10 | Hochstufung | BTIG Research | Neutral → Buy |
| 2021-10-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-07-21 | Bestätigt | BofA Securities | Neutral |
| 2021-07-21 | Bestätigt | Citigroup | Buy |
| 2021-07-21 | Bestätigt | JP Morgan | Overweight |
| 2021-07-21 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2021-07-21 | Bestätigt | Piper Sandler | Neutral |
| 2021-07-21 | Bestätigt | SVB Leerink | Mkt Perform |
| 2021-07-21 | Bestätigt | Stifel | Buy |
| 2021-07-21 | Bestätigt | UBS | Neutral |
| 2021-07-21 | Bestätigt | Wells Fargo | Overweight |
| 2021-07-14 | Bestätigt | Goldman | Buy |
| 2021-06-01 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2021-04-21 | Hochstufung | Oppenheimer | Underperform → Perform |
| 2021-04-21 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2021-04-01 | Eingeleitet | Citigroup | Buy |
| 2020-12-15 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-09-28 | Eingeleitet | Argus | Buy |
| 2020-09-11 | Eingeleitet | Wolfe Research | Outperform |
| 2020-09-08 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Neutral |
| 2020-07-20 | Bestätigt | Bernstein | Outperform |
| 2020-04-28 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-04-17 | Herabstufung | CFRA | Hold → Sell |
| 2020-04-17 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-09 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2020-04-01 | Herabstufung | Oppenheimer | Perform → Underperform |
| 2020-01-27 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2019-12-12 | Bestätigt | Wells Fargo | Outperform |
| 2019-11-21 | Eingeleitet | Oppenheimer | Perform |
| 2019-07-19 | Bestätigt | Canaccord Genuity | Buy |
| 2019-04-22 | Bestätigt | Canaccord Genuity | Buy |
| 2019-04-02 | Eingeleitet | Deutsche Bank | Buy |
| 2018-10-31 | Bestätigt | Piper Jaffray | Overweight |
| 2018-10-19 | Hochstufung | Canaccord Genuity | Hold → Buy |
Alle ansehen
Intuitive Surgical Inc Aktie (ISRG) Neueste Nachrichten
Got $5,000? 2 Unstoppable Growth Stocks to Buy Now and Hold Forever - The Globe and Mail
Got $5,000? 2 Unstoppable Growth Stocks to Buy Now and Hold Forever - The Motley Fool
Intuitive Surgical, Inc. (ISRG): Among the Most Promising Future Stocks According to Hedge Funds - Yahoo Finance
Surgical Robots Market to Surge from USD 11.1 Billion to USD 23.7 Billion by 2029 - openPR.com
Intuitive Surgical Expands into Mexico as UK NHS Scales da Vinci Robot Adoption - openPR.com
Surgical Robot Maker to Become City’s Biggest Employer with $540M Campus Expansion - Peachtree Corners Magazine
Here's How Much You Would Have Made Owning Intuitive Surgical Stock In The Last 10 Years - Benzinga
Robotic Surgery Consumables Market Exclusive Trends Analysis with Forecast to 2031 - openPR.com
Robotics Ethics Market Size 2025 Emerging Demands, Share, - openPR.com
Service Robotics Market Forecast 2025-2032: Global Size, - openPR.com
Intuitive Surgical (ISRG) Impacts UFP Technologies' Business Out - GuruFocus
Short-seller Wolfpack Research long Intuitive Surgical - Investing.com
Wolfpack Research Says Long Intuitive Surgical - marketscreener.com
Intuitive Surgical (ISRG) Impacts UFP Technologies' Business Outlook | ISRG Stock News - GuruFocus
Intuitive Surgical (ISRG) Boosts Share Buyback Program to $4 Bil - GuruFocus
Intuitive Surgical (ISRG) Announces Key Approvals and Stock Repurchase Program Expansion - GuruFocus
Intuitive Surgical (ISRG) Boosts Share Buyback Program to $4 Billion - GuruFocus
Intuitive Surgical Expands Stock Repurchase Program to $4B - TipRanks
Urology Robotics Devices Market to Reach $28.57 Billion by 2033 | CAGR 17.7% | Intuitive Surgical, MicroPort, Asensus - openPR.com
Intuitive Surgical Boosts Stock Repurchase Program To $4 Billion - marketscreener.com
Is Intuitive Surgical (ISRG) The Best Stock to Buy and Hold For 10 Years? - Insider Monkey
12 Best Stocks to Buy and Hold For 10 Years - Insider Monkey
Prediction: 2 Stocks Will Be Worth More Than Palantir Technologies in 2026 - Yahoo Finance
Hedge Fund and Insider Trading News: Bill Ackman, Warren Buffett, David Einhorn, Point72 Asset Management, Irenic Capital Management, Balyasny Asset Management, Phinia Inc (PHIN), Intuitive Surgical Inc (ISRG), and More - Insider Monkey
Intuitive wins new FDA nod for single port robot; Resmed buys diagnostic facility - MedTech Dive
Healthcare Skill Training: Intuitive Surgical India Partners with HSSC - Rediff
Medtech companies try to head off price increases after tariffs - Modern Healthcare
Laparoscopic Surgical Robot Market New Product Development & - openPR.com
Intuitive Surgical Insider Sold Shares Worth $1,248,000, According to a Recent SEC Filing - marketscreener.com
Intuitive Surgical director Amy Ladd sells $4.44m in stock By Investing.com - Investing.com South Africa
Intuitive Surgical director Amy Ladd sells $4.44m in stock - Investing.com Australia
Intuitive surgical director Jami Nachtsheim sells $1.25m in stock By Investing.com - Investing.com Nigeria
Intuitive's (ISRG) da Vinci SP System Gains FDA Approval for New Surgical Procedure | ISRG Stock News - GuruFocus
Intuitive surgical director Jami Nachtsheim sells $1.25m in stock - Investing.com
Intuitive Announces FDA Clearance of da Vinci Single Port for Transanal Local Excision/Resection - GlobeNewswire
Jim Cramer on Intuitive Surgical, Inc. (ISRG): ‘As Relevant As Ever’ - Insider Monkey
Intuitive Surgical (ISRG) Expands FDA Clearance for da Vinci Sys - GuruFocus
FDA Expands Intuitive Surgical (NasdaqGS:ISRG) da Vinci SP System for Advanced Colorectal Surgeries - simplywall.st
Intuitive’s da Vinci SP Wins FDA Nod for Transanal Local Excision/Resection - Medical Product Outsourcing
Intuitive Surgical Receives US FDA Approval for da Vinci Single Port Surgical System - marketscreener.com
Intuitive's da Vinci Single Port system granted new FDA nod (ISRG) - Seeking Alpha
Intuitive earns expanded FDA nod for da Vinci single port system - MassDevice
Intuitive Announces FDA Clearance Of Da Vinci Single Port For Transanal Local Excision/Resection - marketscreener.com
Intuitive Surgical, Inc. (ISRG): Among the Best Stocks to Buy During Recession - Insider Monkey
FDA approves new da Vinci system for colorectal surgery - Investing.com
Intuitive Announces FDA Clearance of da Vinci Single Port for Tr - GuruFocus
Argus Cuts Price Target on Intuitive Surgical to $600 From $630 - marketscreener.com
Intuitive and HSSC come together to strengthen India’s healthcare workforce - Pharmabiz.com
Laparoscopic Devices Market Generated Opportunities, Future - openPR.com
Silicon Valley company's robotic technology helping fight cancer - NBC Bay Area
Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know - MSN
Finanzdaten der Intuitive Surgical Inc-Aktie (ISRG)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):